Cheryl L Willman

Title: Innovations of Cheryl L Willman

Introduction

Cheryl L Willman is a prominent inventor based in Albuquerque, NM (US). She has made significant contributions to the field of cancer treatment through her innovative research and inventions. With a total of 7 patents, her work focuses on developing targeted delivery systems for cancer therapies.

Latest Patents

One of her latest patents is titled "Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same." This invention is directed towards protocells that specifically target hepatocellular and other cancer cells. The protocells comprise a nanoporous silica core with a supported lipid bilayer, along with agents that facilitate cancer cell death. These agents may include traditional small molecules, macromolecular cargo such as siRNA, or protein toxins. The invention also involves histone-packaged plasmid DNA that is disposed within the nanoporous silica core, which can be modified to assist in localizing protocells within the nucleus of cancer cells. The protocells are designed to express peptides involved in therapy and can be used for cancer treatment, particularly hepatocellular cancer, using novel binding peptides that selectively bind to hepatocellular tissue.

Career Highlights

Cheryl has worked with notable organizations such as STC.UNM and Sandia Corporation. Her experience in these companies has contributed to her expertise in the field of cancer research and innovative therapies.

Collaborations

Some of her notable coworkers include C Jeffrey Brinker and Carlee Erin Ashley. Their collaborative efforts have further advanced the research and development of targeted cancer therapies.

Conclusion

Cheryl L Willman is a distinguished inventor whose work in developing protocells for targeted cancer treatment showcases her commitment to advancing medical science. Her innovative patents and collaborations highlight her significant impact in the field of cancer research.